Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
The Trump administration aims to overhaul publicly funded science. Critics say cuts could undermine U.S. leadership that has ...
The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
The new FDA-approved weight loss medicines have changed the game for people with obesity, offering millions of Americans a ...
Injectable drugs like Ozempic and Wegovy may be new to most of the world, but the science behind them are familiar to those in the health field.
We are looking into a health alert, as the FDA has ruled compounded versions of popular drugs used for weight loss will no ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
Black seed oil has been used for centuries in traditional Eastern European, Northern African, and Southwestern Asian medicine. But what is black seed oil good for? It’s still generating buzz today for ...
Pharmalittle: We’re reading about Lilly and Roche weight loss drugs, FDA and compounders, and more
Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback